Literature DB >> 32699088

N-Linked Glycan Sites on the Influenza A Virus Neuraminidase Head Domain Are Required for Efficient Viral Incorporation and Replication.

Henrik Östbye1, Jin Gao2, Mira Rakic Martinez2, Hao Wang1, Jan-Willem de Gier1, Robert Daniels3.   

Abstract

N-linked glycans commonly contribute to secretory protein folding, sorting, and signaling. For enveloped viruses, such as the influenza A virus (IAV), large N-linked glycans can also be added to prevent access to epitopes on the surface antigens hemagglutinin (HA or H) and neuraminidase (NA or N). Sequence analysis showed that in the NA head domain of H1N1 IAVs, three N-linked glycosylation sites are conserved and that a fourth site is conserved in H3N2 IAVs. Variable sites are almost exclusive to H1N1 IAVs of human origin, where the number of head glycosylation sites first increased over time and then decreased with and after the introduction of the 2009 pandemic H1N1 IAV of Eurasian swine origin. In contrast, variable sites exist in H3N2 IAVs of human and swine origin, where the number of head glycosylation sites has mainly increased over time. Analysis of IAVs carrying N1 and N2 mutants demonstrated that the N-linked glycosylation sites on the NA head domain are required for efficient virion incorporation and replication in cells and eggs. It also revealed that N1 stability is more affected by the head domain glycans, suggesting N2 is more amenable to glycan additions. Together, these results indicate that in addition to antigenicity, N-linked glycosylation sites can alter NA enzymatic stability and the NA amount in virions.IMPORTANCE N-linked glycans are transferred to secretory proteins upon entry into the endoplasmic reticulum lumen. In addition to promoting secretory protein maturation, enveloped viruses also utilize these large oligosaccharide structures to prevent access to surface antigen epitopes. Sequence analyses of the influenza A virus (IAV) surface antigen neuraminidase (NA or N) showed that the conservation of N-linked glycosylation sites on the NA enzymatic head domain differs by IAV subtype (H1N1 versus H3N2) and species of origin, with human-derived IAVs possessing the most variability. Experimental analyses verified that the N-linked glycosylation sites on the NA head domain contribute to virion incorporation and replication. It also revealed that the head domain glycans affect N1 stability more than N2, suggesting N2 is more accommodating to glycan additions. These results demonstrate that in addition to antigenicity, changes in N-linked glycosylation sites can alter other properties of viral surface antigens and virions.

Entities:  

Keywords:  IAV composition; N-linked glycosylation sites; NA; glycoprotein maturation; stability; surface antigen; viral replication

Mesh:

Substances:

Year:  2020        PMID: 32699088      PMCID: PMC7495393          DOI: 10.1128/JVI.00874-20

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  58 in total

1.  The influenza virus resource at the National Center for Biotechnology Information.

Authors:  Yiming Bao; Pavel Bolotov; Dmitry Dernovoy; Boris Kiryutin; Leonid Zaslavsky; Tatiana Tatusova; Jim Ostell; David Lipman
Journal:  J Virol       Date:  2007-10-17       Impact factor: 5.103

2.  A DNA transfection system for generation of influenza A virus from eight plasmids.

Authors:  E Hoffmann; G Neumann; Y Kawaoka; G Hobom; R G Webster
Journal:  Proc Natl Acad Sci U S A       Date:  2000-05-23       Impact factor: 11.205

3.  The amino acid following an asn-X-Ser/Thr sequon is an important determinant of N-linked core glycosylation efficiency.

Authors:  J L Mellquist; L Kasturi; S L Spitalnik; S H Shakin-Eshleman
Journal:  Biochemistry       Date:  1998-05-12       Impact factor: 3.162

Review 4.  The intrinsic and extrinsic effects of N-linked glycans on glycoproteostasis.

Authors:  Daniel N Hebert; Lydia Lamriben; Evan T Powers; Jeffery W Kelly
Journal:  Nat Chem Biol       Date:  2014-10-17       Impact factor: 15.040

5.  Polar residues and their positional context dictate the transmembrane domain interactions of influenza A neuraminidases.

Authors:  Johan Nordholm; Diogo V da Silva; Justina Damjanovic; Dan Dou; Robert Daniels
Journal:  J Biol Chem       Date:  2013-02-27       Impact factor: 5.157

6.  Analysis of N-linked glycosylation of hantaan virus glycoproteins and the role of oligosaccharide side chains in protein folding and intracellular trafficking.

Authors:  Xiaohong Shi; Richard M Elliott
Journal:  J Virol       Date:  2004-05       Impact factor: 5.103

Review 7.  Influenza neuraminidase as a vaccine antigen.

Authors:  Maryna C Eichelberger; Hongquan Wan
Journal:  Curr Top Microbiol Immunol       Date:  2015       Impact factor: 4.291

8.  LytA, major autolysin of Streptococcus pneumoniae, requires access to nascent peptidoglycan.

Authors:  Peter Mellroth; Robert Daniels; Alice Eberhardt; Daniel Rönnlund; Hans Blom; Jerker Widengren; Staffan Normark; Birgitta Henriques-Normark
Journal:  J Biol Chem       Date:  2012-02-09       Impact factor: 5.157

9.  Type II transmembrane domain hydrophobicity dictates the cotranslational dependence for inversion.

Authors:  Dan Dou; Diogo V da Silva; Johan Nordholm; Hao Wang; Robert Daniels
Journal:  Mol Biol Cell       Date:  2014-08-27       Impact factor: 4.138

10.  Topological N-glycosylation and site-specific N-glycan sulfation of influenza proteins in the highly expressed H1N1 candidate vaccines.

Authors:  Yi-Min She; Aaron Farnsworth; Xuguang Li; Terry D Cyr
Journal:  Sci Rep       Date:  2017-08-31       Impact factor: 4.379

View more
  6 in total

1.  Design of the Recombinant Influenza Neuraminidase Antigen Is Crucial for Its Biochemical Properties and Protective Efficacy.

Authors:  Jin Gao; Laura Klenow; Lisa Parsons; Tahir Malik; Je-Nie Phue; Zhizeng Gao; Stephen G Withers; John Cipollo; Robert Daniels; Hongquan Wan
Journal:  J Virol       Date:  2021-10-06       Impact factor: 5.103

2.  Antigenic comparison of the neuraminidases from recent influenza A vaccine viruses and 2019-2020 circulating strains.

Authors:  Jin Gao; Xing Li; Laura Klenow; Tahir Malik; Hongquan Wan; Zhiping Ye; Robert Daniels
Journal:  NPJ Vaccines       Date:  2022-07-14       Impact factor: 9.399

Review 3.  Influenza Neuraminidase Characteristics and Potential as a Vaccine Target.

Authors:  Sarah Creytens; Mirte N Pascha; Marlies Ballegeer; Xavier Saelens; Cornelis A M de Haan
Journal:  Front Immunol       Date:  2021-11-16       Impact factor: 7.561

4.  Aberrant Cellular Glycosylation May Increase the Ability of Influenza Viruses to Escape Host Immune Responses through Modification of the Viral Glycome.

Authors:  John F Cipollo; Ian A York; Irina V Alymova; Lisa M Parsons; Nedzad Music; Ram P Kamal; Wen-Pin Tzeng; Cynthia S Goldsmith; Joseph N Contessa; Kevan L Hartshorn; Jason R Wilson; Hui Zeng; Shane Gansebom
Journal:  mBio       Date:  2022-03-14       Impact factor: 7.786

5.  Optimisation of Neuraminidase Expression for Use in Drug Discovery by Using HEK293-6E Cells.

Authors:  Ashley C Campbell; John J Tanner; Kurt L Krause
Journal:  Viruses       Date:  2021-09-22       Impact factor: 5.048

6.  Identification and Characterization of Swine Influenza Virus H1N1 Variants Generated in Vaccinated and Nonvaccinated, Challenged Pigs.

Authors:  Álvaro López-Valiñas; Marta Sisteré-Oró; Sergi López-Serrano; Laura Baioni; Ayub Darji; Chiara Chiapponi; Joaquim Segalés; Llilianne Ganges; José I Núñez
Journal:  Viruses       Date:  2021-10-16       Impact factor: 5.048

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.